Clinical analysis of sinonasal chondrosarcoma in 47 cases
10.3760/cma.j.issn.1673-0860.2020.01.004
- VernacularTitle: 鼻腔鼻窦软骨肉瘤47例临床分析
- Author:
Wanpeng LI
1
;
Hanyu LU
;
Huan WANG
;
Huankang ZHANG
;
Quan LIU
;
Xicai SUN
;
Li HU
;
Dehui WANG
Author Information
1. Department of Otorhinolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai Medwal College, Fudan University, Shanghai 200031, China
- Publication Type:Journal Article
- Keywords:
Nasal cavity;
Paranasal sinuses;
Chondrosarcoma;
Recurrence;
Prognosis
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2020;55(1):14-20
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To discuss the treatment, pathological subtypes and recurrence of sinonasal chondrosarcoma, and to identify the prognostic factors.
Methods:Between January 1994 and May 2018, 47 patients with sinonasal chondrosarcoma who were treated in Eye, Ear, Nose and Throat Hospital, Shanghai Medwal College, Fudan University were retrospectively reviewed, including 19 males and 28 females, aging from 7 months to 71 years old, with a median age of 38 years old. The clinical symptoms, location of tumor, surgical method, pathological subtype, recurrence and prognosis were collected and analyzed. Kaplan-Meier method was used to calculate the disease-specific survival rate, disease-free survival rate and draw survival curve. Log Rank was used to analyze the prognostic factors. Cox regression was used for multivariate analysis.
Results:Except for one patient who gave up treatment after tumor biopsy, other 46 patients underwent radical resection, including 31 cases of endoscopic resection and 15 cases of extranasal approach resection. Thirty-nine patients were diagnosed as conventional intramedullary chondrosarcoma with pathological grade Ⅰ of 24 cases and grade Ⅱ of 15 cases. Six cases were diagnosed as mesenchymal chondrosarcoma while 2 cases were diagnosed as myxoid chondrosarcoma. During an average follow-up period of 56.1 months (17-156 months), 23 patients had recurrence (54.8%, 23/42), among whom 9 patients had re-operations and 5 patients died. Thirty-seven patients survived, including 25 patients survived without tumors. In addition, 5 patients were lost to follow-up, including the patient who gave up treatment after tumor biopsy. Five-year overall survival rate and disease-free survival rate was 84.7% and 34.3%, respectively. Multivariate analysis showed that invasion of skull base was an independent risk factor affecting disease-free survival rate (95% confidence interval: 1.089-5.825, P=0.031).
Conclusions:Radical resection is the primary treatment for sinonasal chondrosarcoma. The most common pathological subtype is conventional intramedullary chondrosarcoma. Sinonasal chondrosarcoma has a high local recurrence rate. The long-term prognosis is well after complete excision of the lesion. The most important cause of death is uncontrollable local disease and invasion of adjacent key structures.
